デフォルト表紙
市場調査レポート
商品コード
1435196

免疫測定自動分析装置市場:製品、用途、エンドユーザー別-2024-2030年の世界予測

Automated Immunoassay Analyzers Market by Product (Chemiluminescence, Enzyme-Linked Fluorescent System, Immunofluorescence), Application (Allergy Testing, Chronic Diseases, Drug Monitoring), End-User - Global Forecast 2024-2030

出版日: | 発行: 360iResearch | ページ情報: 英文 197 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
免疫測定自動分析装置市場:製品、用途、エンドユーザー別-2024-2030年の世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 197 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

免疫測定自動分析装置市場規模は2023年に118億2,000万米ドルと推計され、2024年には126億3,000万米ドルに達し、CAGR 6.92%で2030年には188億9,000万米ドルに達すると予測されます。

免疫測定自動分析装置の世界市場

主な市場の統計
基準年[2023] 118億2,000万米ドル
予測年[2024] 126億3,000万米ドル
予測年 [2030] 188億9,000万米ドル
CAGR(%) 6.92%
免疫測定自動分析装置 Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは免疫測定自動分析装置市場を評価する上で極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます:フォアフロント(F)、パスファインダー(P)、ニッチ(N)、バイタル(V)です。

市場シェア分析

市場シェア分析は、免疫測定自動分析装置市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています:

1-市場の浸透度:主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度:有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化:新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報:市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション:将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています:

1-免疫測定自動分析装置市場の市場規模および予測は?

2-免疫測定自動分析装置市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か?

3-免疫測定自動分析装置市場における技術動向と規制の枠組みは?

4-免疫測定自動分析装置市場における主要ベンダーの市場シェアは?

5-免疫測定自動分析装置市場への参入に適した形態や戦略的手段は?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 世界中で慢性疾患や感染症が蔓延
      • 臨床検査自動化への急速な移行
      • 早期診断と治療に対する意識の高まり
    • 抑制要因
      • 免疫測定自動分析装置の高コストと予算の制約に関連する
    • 機会
      • 免疫測定自動分析装置への新しいテクノロジーの統合
      • 検査室のパフォーマンスを向上させる高度なイムノアッセイ分析装置の登場
    • 課題
      • 訓練を受けた経験豊富な専門家が不足している
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 免疫測定自動分析装置市場:製品別

  • 化学発光
  • 酵素結合蛍光システム
  • 免疫蛍光
  • ラジオイムノアッセイ

第7章 免疫測定自動分析装置市場:用途別

  • アレルギー検査
  • 慢性疾患
  • 薬物監視
  • 内分泌学
  • 感染症

第8章 免疫測定自動分析装置市場:エンドユーザー別

  • 学術調査機関
  • バイオテクノロジー企業および製薬企業
  • 診断試験所
  • 病院

第9章 南北アメリカの免疫測定自動分析装置市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の免疫測定自動分析装置市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの免疫測定自動分析装置市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析:主要企業別
  • 競合シナリオ主要企業別の分析

第13章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Abbott Laboratories
    • Arlington Scientific, Inc.
    • Becton Dickinson and Company
    • Bio-Rad Laboratories, Inc.
    • Biobase Biodusty(Shandong), Co., Ltd.
    • bioMerieux SA
    • Carolina Liquid Chemistries Corp.
    • Charles River Laboratories
    • Chengdu Vacure Biotechnology Co., Ltd.
    • Danaher Corporation
    • F. Hoffmann-La Roche AG
    • Getein Biotech, Inc.
    • Hipro Biotechnology Co., Ltd.
    • Hitachi, Ltd.
    • Illumina, Inc.
    • Laboratory Corporation of America Holdings
    • Luminex Corporation by DiaSorin Company
    • Medline Industries, LP
    • Meril Life Sciences Pvt. Ltd.
    • PerkinElmer, Inc.
    • PHC Europe B.V.
    • Qiagen N.V.
    • Randox Laboratories
    • Siemens Healthineers
    • Sysmex Corporation
  • 主要な製品ポートフォリオ

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. AUTOMATED IMMUNOASSAY ANALYZERS MARKET RESEARCH PROCESS
  • FIGURE 2. AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. AUTOMATED IMMUNOASSAY ANALYZERS MARKET DYNAMICS
  • FIGURE 7. AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. AUTOMATED IMMUNOASSAY ANALYZERS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. AUTOMATED IMMUNOASSAY ANALYZERS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. AUTOMATED IMMUNOASSAY ANALYZERS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 6. AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY CHEMILUMINESCENCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY ENZYME-LINKED FLUORESCENT SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY IMMUNOFLUORESCENCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY RADIOIMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY ALLERGY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY CHRONIC DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY DRUG MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY ENDOCRINOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 17. AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY BIOTECH & PHARMA COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY DIAGNOSTIC TEST LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. AUTOMATED IMMUNOASSAY ANALYZERS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 149. AUTOMATED IMMUNOASSAY ANALYZERS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 150. AUTOMATED IMMUNOASSAY ANALYZERS MARKET LICENSE & PRICING
目次
Product Code: MRR-FF012EDC38D5

[197 Pages Report] The Automated Immunoassay Analyzers Market size was estimated at USD 11.82 billion in 2023 and expected to reach USD 12.63 billion in 2024, at a CAGR 6.92% to reach USD 18.89 billion by 2030.

Global Automated Immunoassay Analyzers Market

KEY MARKET STATISTICS
Base Year [2023] USD 11.82 billion
Estimated Year [2024] USD 12.63 billion
Forecast Year [2030] USD 18.89 billion
CAGR (%) 6.92%
Automated Immunoassay Analyzers Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Automated Immunoassay Analyzers Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Automated Immunoassay Analyzers Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Automated Immunoassay Analyzers Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Arlington Scientific, Inc., Becton Dickinson and Company, Bio-Rad Laboratories, Inc., Biobase Biodusty(Shandong), Co., Ltd., bioMerieux SA, Carolina Liquid Chemistries Corp., Charles River Laboratories, Chengdu Vacure Biotechnology Co., Ltd., Danaher Corporation, F. Hoffmann-La Roche AG, Getein Biotech, Inc., Hipro Biotechnology Co., Ltd., Hitachi, Ltd., Illumina, Inc., Laboratory Corporation of America Holdings, Luminex Corporation by DiaSorin Company, Medline Industries, LP, Meril Life Sciences Pvt. Ltd., PerkinElmer, Inc., PHC Europe B.V., Qiagen N.V., Randox Laboratories, Siemens Healthineers, and Sysmex Corporation.

Market Segmentation & Coverage

This research report categorizes the Automated Immunoassay Analyzers Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Chemiluminescence
    • Enzyme-Linked Fluorescent System
    • Immunofluorescence
    • Radioimmunoassay
  • Application
    • Allergy Testing
    • Chronic Diseases
    • Drug Monitoring
    • Endocrinology
    • Infectious Diseases
  • End-User
    • Academic Research Institutes
    • Biotech & Pharma Companies
    • Diagnostic Test Laboratories
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Automated Immunoassay Analyzers Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Automated Immunoassay Analyzers Market?

3. What are the technology trends and regulatory frameworks in the Automated Immunoassay Analyzers Market?

4. What is the market share of the leading vendors in the Automated Immunoassay Analyzers Market?

5. Which modes and strategic moves are suitable for entering the Automated Immunoassay Analyzers Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Automated Immunoassay Analyzers Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of chronic and infectious diseases across the globe
      • 5.1.1.2. Rapid shift towards clinical laboratory automation
      • 5.1.1.3. Surging awareness of early diagnosis and treatments
    • 5.1.2. Restraints
      • 5.1.2.1. Associated high cost of automated immunoassay analyzers and budget constraints
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of novel technologies in automated immunoassay analyzers
      • 5.1.3.2. Emergence of advanced immunoassay analyzer for enhanced laboratory performance
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of trained and experienced professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Automated Immunoassay Analyzers Market, by Product

  • 6.1. Introduction
  • 6.2. Chemiluminescence
  • 6.3. Enzyme-Linked Fluorescent System
  • 6.4. Immunofluorescence
  • 6.5. Radioimmunoassay

7. Automated Immunoassay Analyzers Market, by Application

  • 7.1. Introduction
  • 7.2. Allergy Testing
  • 7.3. Chronic Diseases
  • 7.4. Drug Monitoring
  • 7.5. Endocrinology
  • 7.6. Infectious Diseases

8. Automated Immunoassay Analyzers Market, by End-User

  • 8.1. Introduction
  • 8.2. Academic Research Institutes
  • 8.3. Biotech & Pharma Companies
  • 8.4. Diagnostic Test Laboratories
  • 8.5. Hospitals

9. Americas Automated Immunoassay Analyzers Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Automated Immunoassay Analyzers Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Automated Immunoassay Analyzers Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. Abbott Laboratories
    • 13.1.2. Arlington Scientific, Inc.
    • 13.1.3. Becton Dickinson and Company
    • 13.1.4. Bio-Rad Laboratories, Inc.
    • 13.1.5. Biobase Biodusty(Shandong), Co., Ltd.
    • 13.1.6. bioMerieux SA
    • 13.1.7. Carolina Liquid Chemistries Corp.
    • 13.1.8. Charles River Laboratories
    • 13.1.9. Chengdu Vacure Biotechnology Co., Ltd.
    • 13.1.10. Danaher Corporation
    • 13.1.11. F. Hoffmann-La Roche AG
    • 13.1.12. Getein Biotech, Inc.
    • 13.1.13. Hipro Biotechnology Co., Ltd.
    • 13.1.14. Hitachi, Ltd.
    • 13.1.15. Illumina, Inc.
    • 13.1.16. Laboratory Corporation of America Holdings
    • 13.1.17. Luminex Corporation by DiaSorin Company
    • 13.1.18. Medline Industries, LP
    • 13.1.19. Meril Life Sciences Pvt. Ltd.
    • 13.1.20. PerkinElmer, Inc.
    • 13.1.21. PHC Europe B.V.
    • 13.1.22. Qiagen N.V.
    • 13.1.23. Randox Laboratories
    • 13.1.24. Siemens Healthineers
    • 13.1.25. Sysmex Corporation
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing